Study on the Construction of a Comprehensive Management Platform for Drug Safety Monitoring Data at Municipal Level

doi:10.16153/j.1002-7777.2018.11.002

PDF(924 KB)

Chinese Pharmaceutical Affairs ›› 2018, Vol. 32 ›› Issue (11) : 1458-1461. DOI: 10.16153/j.1002-7777.2018.11.002

Supervision Administration

Study on the Construction of a Comprehensive Management Platform for Drug Safety Monitoring Data at Municipal Level

Cao Lujuan, Zhao Xia

Author information +

History +

Abstract

Objective: To achieve management and utilization of drug safety monitoring data through the construction of a comprehensive management platform for drug safety monitoring data. Methods: Based on informationization technology and the monitoring system of national drug adverse reaction, data collection and retrieval, report quality management, data statistical analysis, real-time risk warning and risk signal mining were integrated to achieve one-stop service. Guided by "machine substitution", the computational tasks difficult to be carried out were converted into computer-based tasks. Visual models were introduced for data analysis and signal mining, reflecting the value creation based on data. Results: The comprehensive management platform can effectively manage and analysis drug safety monitoring data of the whole city and greatly improve the monitoring efficiency and the risk early warning capability. Conclusion: The management platform has a certain role in promoting the intelligent monitoring of drug safety and has a better application prospect.

Key words

municipal level;drug safety monitoring;comprehensive management platform for data

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

Cao Lujuan, Zhao Xia. Study on the Construction of a Comprehensive Management Platform for Drug Safety Monitoring Data at Municipal Level[J]. Chinese Pharmaceutical Affairs, 2018, 32(11): 1458-1461 https://doi.org/10.16153/j.1002-7777.2018.11.002

References

[1] 路长飞,崔小康,刘文文等. 省级药品不良反应监测服务药品安全监管工作模式探讨[J]. 中国药物警戒, 2018,15(1):24-27.
[2] 樊亭亭,田侃,孙骏. 药品不良反应监测机构建设探讨[J]. 医学与社会,2012,25(2):60-62.
[3] 赵霞,陈瑶,廖俊,于峰等. 基于医药大数据的药品不良反应信号挖掘探讨[J]. 中华医院管理杂志,2017, 33(5):373-376.
[4] 王玲. 试论医疗大数据给药品安全性监测与评价带来的机遇和挑战[J]. 中国药物警戒,2015,12(11):660-664.
[5] 刘巍,李馨龄,程刚等. 我国药品不良反应报告质量评估现状的分析与思考[J]. 中国药物警戒,2014,11(9):561-566.
[6] 朱磊,黄萍,李颖. 我国药品不良反应监测现状及存在问题[J]. 中国药事,2016,30(7):729-734.
[7] 王文沛,邵蓉. 我国地方药品不良反应专业监测机构建设现状调研分析[J]. 中国药业,2011,20(8):5-7.
[8] 金璐. 药品不良反应现状及对策[J]. 医学信息,2013, 26(4):27-28.
[9] 严寓均. 药品不良反应监测的现状及存在的问题[J]. 临床合理用药,2009,2(19):77-78.
[10] 国家食品药品监督管理总局. 2012年国家药品不良反应监测年度报告[J]. 中国新药杂志,2013,8:861-862.
[11] 国家食品药品监督管理总局. 国家药品不良反应监测年度报告(2015年)[EB/OL].(2016-07-13)[2018-04-12] http://www.sda.gov.cn/WS01/CL0844/158940.html.
[12] 国家食品药品监督管理总局. 国家药品不良反应监测年度报告(2016年)[EB/OL].(2017-04-28)[2018-04-12] http://www.sda.gov.cn/WS01/CL0844/172167.html.
[13] 国家食品药品监督管理总局. 国家药品不良反应监测年度报告(2017年)[EB/OL].(2018-04-16)[2018-04-12] http://www.cdr-adr.org.cn/xwdt/201804/t20180419_20011.html.
[14] 张婧媛,白羽霞,韩晟等. 数据挖掘方法检测药品不良反应信号的应用研究[J]. 药物不良反应杂志, 2016,18(6):412-416.
[15] 任经天,王胜锋,侯永芳,等. 常用药品不良反应信号检测方法介绍[J]. 中国药物警戒,2011,8(5):369-372.
[16] 沈璐,刘巍,范燕,等. 我国药品不良反应监测模式的趋势分析[J]. 中国药物警戒,2017,14(5):295-297.
[17] 沈璐,刘巍,范燕,等. 论我国药品不良反应监测技术工作的发展阶段[J]. 中国药物警戒,2012,9(3):146-149.
[18] Marie Lindquist. 全球药物警戒的挑战与发展区前景[R]. 杭州:国家药品不良反应监测中心第六届中国药物警戒大会,2017.
[19] 周应群,邢丽秋,刘东红. 北京市医疗机构药品不良反应监测工作调研[J]. 中国药物警戒,2017,1(8):477-480.
[20] 李瑶,谢望时,李醉,等. 昆明市三甲医院医务人员药品不良反应认知度调查研究[J]. 昆明医科大学学报, 2014,35(7):41-44.品不良反应认知度调查研究[J]. 昆明医科大学学报,2014,35(7):41-44.